Medifast (NYSE: MED) reported Q3 EPS of $0.47, $0.11 better than the analyst estimate of $0.36. Revenue for the quarter came in at $74 million versus the consensus estimate of $76.1 million.

For earnings history and earnings-related data on Medifast (MED) click here.